Agilent Technologies Inc. (A1GI34)
Market Closed
11 Jun, 19:55
B3 B3 Primary R$
349. 65
0
0%
R$
197.5B Market Cap
32.64 P/E Ratio
0.79% Div Yield
100 Volume
5.41 Eps
R$ 349.65
Previous Close Want to track A1GI34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
A1GI34 closed yesterday higher at R$349.65, an increase of 0% from Wednesday's close, completing a monthly increase of 23.3377% or R$66.16. Over the past 12 months, A1GI34 stock lost -9.1865%.
A1GI34 pays dividends to its shareholders, with the most recent payment made on Apr 28, 2026.
The last earnings report, released on May 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
Agilent Technologies Inc. (A1GI34) FAQ
What is the stock price today?
The current price is R$349.65.
On which exchange is it traded?
Agilent Technologies Inc. is listed on B3.
What is its stock symbol?
The ticker symbol is A1GI34.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.79%.
What is its market cap?
As of today, the market cap is 197.5B.
Has Agilent Technologies Inc. ever had a stock split?
No, there has never been a stock split.
Agilent Technologies Inc. Profile
| Professional Services Industry | Industrials Sector | Mr. Padraig McDonnell CEO | B3 Exchange | - ISIN |
| BR Country | 18,000 Employees | - Last Dividend | - Last Split | 18 Nov 1999 IPO Date |
Overview
Agilent Technologies, Inc. is a global company that delivers specialized solutions aimed at the life sciences, diagnostics, and applied chemical industries. It undertakes its operations through three main segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. With its inception in 1999 and based in Santa Clara, California, Agilent has carved a niche for itself by focusing on providing in-depth, application-focused solutions and services that cater to the intricate needs of its diverse clientele across the globe.
Products and Services
- Life Sciences and Applied Markets: This segment encompasses a broad spectrum of high-precision instruments and software, including liquid chromatography (LC) systems and components, LC mass spectrometry systems, gas chromatography (GC) systems and components, GC mass spectrometry systems, and various spectroscopy instruments among others. It further extends to laboratory essentials like cell analysis systems, laboratory automation and robotics, vacuum pumps, and measurement technologies. The emphasis here is on supporting complex analytical workflows in research and development.
- Diagnostics and Genomics: Focused on enhancing the capabilities in genomics and diagnostics, this segment offers a range of services and products related to genomics, nucleic acid contract manufacturing, pathology, companion diagnostics, and biomolecular analysis. Agilent's efforts in this area aim to propel advancements in personalized medicine and ensure that diagnostics keep pace with the evolving health care landscape.
- Agilent CrossLab: The CrossLab segment integrates a comprehensive suite of products and services designed to optimize laboratory operations and increase efficiency. It offers a variety of GC and LC columns, sample preparation products, custom chemistries, and numerous laboratory instrument supplies. Beyond products, CrossLab's services portfolio is broad, including instrument repairs, maintenance, installations, compliance support, software solutions, asset management, and consulting services. The objective of Agilent CrossLab is to streamline the workflow and operational aspects of laboratories, ensuring they function smoothly and effectively.
Contact Information
Address: 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051
Phone: 800 227 9770
Website: https://www.agilent.com
